COVID-19

Laboratory workflows for an unprepared world

Revolutionizing laboratory workflows

"COVID-19 shined a light on the bottleneck of moving large volumes of patient samples into high throughput assay workflows. Even with the heroic efforts in expanding floor space and adding staff, it was clear that the number of tests that could be processed was still short of meeting demand. It was this specific workflow constraint that we wanted to solve and the RHINOstic™ was born."

Cofounders Richard Novak, PhD and Michael Springer, PhD

Making lab testing 10x more efficient

Less man power. More testing. Precise results.

CURRENT STATE

1.5 Million

Tests per day

WHAT WE NEED

4 Million

Tests per day

Testing remains critical

"The race to contain the spread of COVID-19 and its new variants requires both vaccination and testing. Testing is essential to control transmission as vaccines are rolled out. With a world population reaching 8 billion, scalability is critical."

Patrick Arensdorf, Director of the CATCH program collaboration between Stanford Unversity and the Chan Zuckerberg Biohub

Strain on laboratory workforce

“Nearly a year into a pandemic that has claimed more than 276,000 American lives, some 193 million tests for the coronavirus have been processed nationwide. Millions more will be needed to detect and contain the virus in the months ahead. Behind these staggering figures are thousands of scientists who have been working nonstop to identify the coronavirus in the people it infects. Across the nation, testing teams are grappling with burnout, repetitive-stress injuries and an overwhelming sense of doom.”

New York Times, 02 Dec 2020, ‘Nobody Sees Us’

Dr Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases

“We should be flooding the system with tests to determine the penetration of the asymptomatic spread.”

Get in touch

Let's make a difference